RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain
about
Chemical genetics approaches for selective intervention in epigeneticsBromodomain Inhibitor Review: Bromodomain and Extra-terminal Family Protein Inhibitors as a Potential New Therapy in Central Nervous System TumorsThe bromodomain: from epigenome reader to druggable targetDual kinase-bromodomain inhibitors for rationally designed polypharmacologySelective Chemical Modulation of Gene Transcription Favors Oligodendrocyte Lineage ProgressionNovel concepts in HDL pharmacology.Structure-Based Design of γ-Carboline Analogues as Potent and Specific BET Bromodomain InhibitorsAtad2 is a generalist facilitator of chromatin dynamics in embryonic stem cellsCholesterol, inflammation and innate immunityRSK3: A regulator of pathological cardiac remodelingTargeting bromodomains: epigenetic readers of lysine acetylationThe mechanisms behind the therapeutic activity of BET bromodomain inhibitionInhibition of BET bromodomains as a therapeutic strategy for cancer drug discoveryTargeting BET bromodomains for cancer treatmentA Novel Phenanthridionone Based Scaffold As a Potential Inhibitor of the BRD2 Bromodomain: Crystal Structure of the ComplexAn Epigenetic Compound Library Screen Identifies BET Inhibitors That Promote HSV-1 and -2 Replication by Bridging P-TEFb to Viral Gene Promoters through BRD4Predictions of Ligand Selectivity from Absolute Binding Free Energy CalculationsAlkaline phosphatase: a novel treatment target for cardiovascular disease in CKD.BET bromodomain proteins and epigenetic regulation of inflammation: implications for type 2 diabetes and breast cancer.Drug Discovery Targeting Bromodomain-Containing Protein 4.Selective BET bromodomain inhibition as an antifungal therapeutic strategyPrivileged diazepine compounds and their emergence as bromodomain inhibitors.BET and HDAC inhibitors induce similar genes and biological effects and synergize to kill in Myc-induced murine lymphomaHDL and cognition in neurodegenerative disorders.BET protein inhibitor JQ1 attenuates Myc-amplified MCC tumor growth in vivo.Brd4 is essential for IL-1β-induced inflammation in human airway epithelial cellsAssessing cellular efficacy of bromodomain inhibitors using fluorescence recovery after photobleaching.Alternative modulation of protein-protein interactions by small moleculesDevelopment of novel cellular histone-binding and chromatin-displacement assays for bromodomain drug discoveryMolecular docking and dynamics simulation study of flavonoids as BET bromodomain inhibitors.Perhexiline activates KLF14 and reduces atherosclerosis by modulating ApoA-I production.Design and characterization of bivalent BET inhibitors.Assessment of Bromodomain Target Engagement by a Series of BI2536 Analogues with Miniaturized BET-BRET.Accurate calculation of the absolute free energy of binding for drug molecules.Selective and reversible suppression of intestinal stem cell differentiation by pharmacological inhibition of BET bromodomainsThe BET-Bromodomain Inhibitor JQ1 Reduces Inflammation and Tau Phosphorylation at Ser396 in the Brain of the 3xTg Model of Alzheimer's DiseaseModeling cis-regulation with a compendium of genome-wide histone H3K27ac profiles.Bromodomain and extra-terminal protein mimic JQ1 decreases inflammation in human vascular endothelial cells: Implications for pulmonary arterial hypertension.Photoreceptor protection via blockade of BET epigenetic readers in a murine model of inherited retinal degeneration.Epigenetic drug discovery for Alzheimer's disease.
P2860
Q26740037-A3AE892D-C2C5-4BC1-9114-FE44D30CC314Q26744268-C318CBAA-F572-4493-B52E-E880EBCA728DQ26999935-5DDBCA03-4073-48F6-A802-4863F6FD5A37Q27681935-66842F15-9B25-40E2-912A-38FDF049E32FQ27684429-8ABE33E2-A47C-43D2-B46B-5CA2CE2F59FEQ27692691-AC383568-2BA5-4E2A-A3A5-0978BB9105E1Q27701027-DBD4AE25-22C4-4FA0-A74A-C723DD39FDBAQ27702290-8ED28A1A-347A-487E-87FB-7F0E2BA6E045Q28086912-9393A175-5967-4B77-A8F2-19DEAEE7FC01Q28086916-54D68587-7623-47AD-BB90-F2511019FE3CQ28238635-A1C88812-F4C3-40D5-BFF2-0E453B0BD0D2Q28241504-0848C5CB-F8CC-484C-AECE-732D78F6150DQ28260105-7724B223-7091-409A-9F22-5D3BB356A897Q28263519-0AC99F43-5E2E-4DCA-9DF4-5B2447C0AC4FQ28552504-7D1748D6-B2BB-4434-8E99-843A569E4CF5Q28552849-429C3B24-86FB-41A3-BB27-1972C69CF3ADQ28818600-0E5359E3-3EEE-4667-A881-1A121EDC0E7BQ30234466-3285CD7E-5124-43E3-88C1-54184C5FAE39Q30248629-E536676D-B2B4-4231-B8E7-17779044AEDCQ30352390-81DDFE99-0DA7-4EC7-AFF0-3C7B923164C2Q30354737-3ADC22F4-ABEC-4819-9375-C91A41A150A9Q33671341-7C3A43F2-5C84-4669-85F0-96F29CFFBD44Q33853887-AD1F9874-C957-4583-A1E8-213D1716823FQ34614842-C11295ED-47EB-4CFA-9EC9-8746971BBB19Q35066871-6FBCDC5F-BDEB-44D3-9E5A-F86806B74D87Q35156050-35655838-BA6E-4E97-8EE0-5FA7248BDB3DQ35220027-46B5F819-52C3-4209-AA86-7C63DB380BF6Q35620999-BEBCD48E-CEB6-46E9-9B12-381514477D83Q36082984-5B8DEB1D-3B9B-4AE1-A51D-F5B1FD839F8EQ36096159-A13AD73C-661E-49FC-A8E6-CF648B48E73DQ36165683-EAFE8456-0F49-4752-8F88-0F93F77CCA99Q36172939-70C0C3EC-69D5-4547-A96B-106AE6657915Q36198013-4A7868A7-C5D0-4A66-8CFE-07E8A4BDDB9DQ36427764-1B731E14-B58B-46DF-8742-A588748C671DQ36559908-4FF5DF32-92A0-4F71-99DB-6A4988EE3875Q37261981-C9238810-E725-4887-AEA3-84C0CA75CBE3Q37313704-82DD8161-880C-4CF3-8EFA-E88EE04841FAQ37561236-D066CC24-0DBD-45DA-8D88-88365E60E273Q37595667-2971BE5A-EFE3-45DF-AC0F-BFEB8110F3E7Q38225708-660CDA87-02A0-488E-AF61-F9448921E2AD
P2860
RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
RVX-208, an inhibitor of BET t ...... ity for the second bromodomain
@ast
RVX-208, an inhibitor of BET t ...... ity for the second bromodomain
@en
RVX-208, an inhibitor of BET t ...... ity for the second bromodomain
@nl
type
label
RVX-208, an inhibitor of BET t ...... ity for the second bromodomain
@ast
RVX-208, an inhibitor of BET t ...... ity for the second bromodomain
@en
RVX-208, an inhibitor of BET t ...... ity for the second bromodomain
@nl
prefLabel
RVX-208, an inhibitor of BET t ...... ity for the second bromodomain
@ast
RVX-208, an inhibitor of BET t ...... ity for the second bromodomain
@en
RVX-208, an inhibitor of BET t ...... ity for the second bromodomain
@nl
P2093
P2860
P50
P3181
P356
P1476
RVX-208, an inhibitor of BET t ...... ity for the second bromodomain
@en
P2093
Beatriz Diez-Dacal
Chas Bountra
Christopher Wells
Deborah Brotherton
Hannah Lingard
Ildiko Felletar
Martin Philpott
Sarah Martin
P2860
P304
P3181
P356
10.1073/PNAS.1310658110
P407
P50
P577
2013-12-03T00:00:00Z